Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Arthritis gene therapy.

P D Robbins¹, C H Evans

¹Department of Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.

Drugs of Today (Barcelona, Spain : 1998)

|September 16, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Home delivery for chondrocytes.

Osteoarthritis and cartilage·2025

Same author

How to Cure Rhus Poisoning.

The Homoeopathic physician·2023

Same author

Enthesis: not the same in each localisation - a molecular, histological and biomechanical study.

European cells & materials·2022

Same author

Mechanical and strain behaviour of human Achilles tendon during in vitro testing to failure.

European cells & materials·2022

Same author

Reverse dynamisation: a modern perspective on Stephan Perren's strain theory.

European cells & materials·2021

Same author

Healing of sub-critical femoral osteotomies in mice is unaffected by tacrolimus and deletion of recombination activating gene 1.

European cells & materials·2021

Same journal

Monoclonal antibodies for treatment of osteoporosis.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Mitapivat for sickle cell disease and thalassemia.

Drugs of today (Barcelona, Spain : 1998)·2023

Same journal

Cenegermin for the treatment of dry eye disease.

Drugs of today (Barcelona, Spain : 1998)·2023

See all related articles

Gene therapy offers a novel approach to rheumatoid arthritis (RA) treatment by delivering therapeutic genes to target cells. This review explores progress in gene transfer methods for RA, highlighting a new clinical trial.

Area of Science:

Rheumatology and Immunology
Molecular Biology
Biotechnology

Background:

Current rheumatoid arthritis (RA) therapies have limitations.
Targeting anti-inflammatory proteins to disease sites like joints is challenging.
Gene therapy presents a novel strategy for RA treatment.

Purpose of the Study:

To review gene therapy approaches for rheumatoid arthritis (RA).
To summarize progress in developing gene transfer methods for RA treatment.
To highlight the initiation of the first RA gene therapy clinical trial.

Main Methods:

Review of existing literature on gene therapy for RA.
Analysis of gene transfer strategies targeting specific cells (e.g., synovial cells, T-cells).

Related Experiment Videos

Discussion of advancements in delivering therapeutic genes for RA.

Main Results:

Significant progress has been made in developing gene therapy strategies for RA.
The first clinical trial for RA gene therapy has recently commenced.
Gene transfer offers a promising method for targeting therapeutic agents to disease sites.

Conclusions:

Gene therapy is an emerging and promising approach for rheumatoid arthritis treatment.
Advancements in gene transfer methods are crucial for effective RA management.
Further research and clinical trials are essential to realize the full potential of gene therapy in RA.